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SUMMARY SeveralstudiesindicatethatHIV-infected
womencontinuetohavechildren.Wesetouttodetermine
thetrendinHIVtransmissionatsubsequentpregnancies.
From2002^2003,pregnantwomenwereenrolledinasingle
dosenevirapine-basedPreventionofMother-to-Child
TransmissionofHIV(PMTCT)programme.Sixyearslater,
womenwithsubsequentchildreninthiscohortwereident-
ifiedandtheirchildren’sHIVstatusdetermined.From330
identifiedHIV-infectedmothers,73hadsecond/subsequent
childrenwithHIVresults.Ofthese,nine(12.3%,95%confi-
denceinterval[CI]:4.6^20. 1%)childrenwereHIV-infected.Of
the73secondchildren,51hadoldersiblingswhohadbeen
initiallyenrolledinthestudywithdefinitiveHIVresultswith
aninfectionrateof17/51(33.3%,95%CI:19.9^46.7).About
35%ofthewomenhadbeenonantiretroviraldrugs.These
resultsdemonstratelowersubsequentHIVtransmission
ratesinwomenonanationalPMTCTprogrammeinaresource-
poorsettingwiththeadventofantiretroviraltherapy.
Introduction
With the improvements in HIV care and management,
HIV-infected women are now considering having more
children. Several reports indicate that women are going
through many cycles of PMTCT (Prevention of Mother to
Child Transmission of HIV).
1,2 This problem has become
signiﬁcant in areas of high HIV prevalence, particularly
where resources are few and breastfeeding is the norm.
Single dose nevirapine, which has been the mainstay of
PMTCT in developing countries, can have an impact on sub-
sequent pregnancies. Its use results in the selection of resist-
ant mutants among HIV-infected women.
3–5 The
effectiveness of a single dose of nevirapine in subsequent
pregnancies has been questioned. However, three studies in
Africa found that there was no reduction in efﬁcacy when
used consecutively.
6–8 With better access to antiretroviral
treatment for pregnant women and better counselling, but
with advanced maternal disease, the transmission of HIV
infection in subsequent pregnancies in a breastfeeding popu-
lation makes it important to be sure.
With this background we set out to determine HIV trans-
mission rates among a cohort of mothers who had been
enrolled in a PMTCT programme and who had two consecu-
tive pregnancies. We compared known risk factors between
the two pregnancies.
Methods
Setting
The study was conducted at three primary maternal child
health clinics in peri-urban areas around Harare (namely,
Epworth, Seke North and St Mary’s) in Zimbabwe.
Design
This was a descriptive cross-sectional study done on a ceased
observational cohort of HIV-infected women who had been
enrolled in a PMTCT programme and who had been followed
up for 15 months after delivery.
Background
Between 2002 and 2003, pregnant women were enrolled into
the Better Health for the African Mother and Child
(BHAMC) study from 36 weeks of gestation, after obtaining
their informed consent. The aim of the initial study was to
explore the role of sexually transmitted infections (STIs) in
pregnancy outcome without considering prematurity – a
late enrolment was, therefore, ideal. Pre- and post-HIV test
counselling was offered as part of the national PMTCT
programme. Baseline characteristics collected included:
sociodemographic information; medical history of STIs;
gynaecological examination ﬁndings; specimen collection
for full blood counts; serology for herpes simplex type 1
and syphilis; and high vaginal swabs for culture. All
HIV-infected women were given a single dose of nevirapine
at delivery; their infants had similar doses, according to the
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9 The infants
were then followed up and the HIV status was determined.
The proportion of HIV-infected infants was 21.8% (95%
conﬁdence interval [CI] 217.8–25.8) which has been pre-
viously reported.
10
Study activities
A subsequent pregnancy/second pregnancy was deﬁned as
the ﬁrst pregnancy occurring after the initial enrolment preg-
nancy. Between 2008 and 2009 mothers who had been
enrolled in this study and who had subsequent children/
second pregnancy were identiﬁed through community
support groups and clinic registers. All identiﬁed women
agreed to participate and were interviewed. The information
obtained was validated with known information about the
women from a previous study. Important additional infor-
mation included: the outcome of the enrolment pregnancy;
number of children since enrolment; and pattern and breast-
feeding duration of subsequent children. The maternal
health cards were examined for medical records pertaining
to CD4 counts and antiretroviral (ARV) therapy. Blood was
drawn from the children for HIV testing. All the information
from the mothers and children was collected on the initial
visit. Infants who were still breastfeeding had blood
samples later collected in order to conﬁrm their HIV infec-
tion status after the cessation of breastfeeding.
All HIV-infected children were referred for the appropriate
care and support. Informed consent was sought from the
mothers and the study was approved by the Medical
Research Council of Zimbabwe.
After determining the HIV infection rates in subsequent
pregnancies, we retrospectively looked for the HIV results
and information on enrolment children of same mothers.
We compared the HIV transmission rates for the initial enrol-
ment children and subsequent/second children.
Laboratory methods
The children’s blood samples were processed and tested for
HIV with DNA polymerase chain reaction (PCR) 1.5 (Roche
Diagnostics, Indianapolis, USA), if the children were aged
less than 15 months, and rapid HIV antibody tests,
Determine (Abbott Diagnostics, Illinois, USA) and Oraquick
(Abbott Diagnostics) if they were aged 15 months or older.
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If the Determine and Oraquick test results were discordant,
the DNA PCR test was used for conﬁrmation.
Statistical analysis
Data were entered and analysed using Stata version 10
(Texas, USA). A table showing characteristics of HIV-
infected women and their infants with subsequent pregnancy
was presented. HIV transmission rates and their 95% CIs
were calculated for the second and ﬁrst pregnancies in the
same women. The two sample test for proportion was used
to compare these transmission rates. The Student’s t-test
was used to compare means and the Pearson chi-square test
was used to compare proportions. Univariate odds ratios
(ORs) and their 95% CIs for mother-to-child transmission
were calculated for known biological factors, such as
reported exclusive breastfeeding duration and mother and
infant nevirapine intake for the second pregnancy.
Results
Table 1 describes the characteristics of the study population,
i.e. of mothers with subsequent children. The majority
reported being married and 30% had changed their spouses
after the initial enrolment. The pill was the common
method of contraception (47%). Thirty-nine percent of
these women had lost the child from the initial pregnancy
for which they had initially been enrolled in the study.
From 434 HIV-infected mothers, 79 (18.2%) had died by
2008 and 25 (5.8%) were unable to be traced. Of the remain-
ing 330 eligible women, 81 (24.5%) had second/subsequent
pregnancies. Of these, eight children were not tested for HIV
because they had died before the study. Of the 73 children
who were tested, nine (12.3%; 95% CI: 4.6–20.1%) were
HIV-infected.
Of the 73 second/subsequent children with HIV infection
results, 51 (70%) had older siblings who had been initially
enrolled in this study with deﬁnitive HIV results. Of these
older siblings, 17 (33.3%; 95% CI: 19.9–46.7) were HIV-
infected. Of the remaining 22 ﬁrst siblings, 18 died with no
ultimate HIV test (cause of death unknown) and four were
lost to follow-up.
The difference in HIV transmission rates between the ﬁrst
and second pregnancies was statistically signiﬁcant (P ¼
0.005).
A comparison of known factors associated with HIV trans-
mission between the initial and subsequent pregnancy
resulted in the following observations.
Breastfeeding
At initial pregnancy, 36 of the 51 (76.2%) were still breast-
feeding at nine months. For the subsequent pregnancy the
mean duration of breastfeeding was 10.0 months (standard
deviation [sd] 7.2) in those infected with HIV and 10.1
Table 1 Characteristics of HIV-infected women and their
infants with subsequent pregnancy
Characteristics of HIV-infected women and their
second infants Frequency
Mother’s age in years (n ¼ 76)
Mean (standard deviation, SD) 30.4 (4.4)
Marital status (n ¼ 74)
Married 56 (75.7%)
Change of spouse since initial enrolment (n ¼ 74)
Yes 22 (29.7%)
Outcome of ﬁrst child in cohort (n ¼ 75)
Dead 29 (38.7%)
Type of contraception after ﬁrst enrolment (n ¼ 60)
Pill 28 (46.7%)
Depo Provera 17 (28.3%)
Condom 8 (13.3%)
Intra uterine contraceptive device 1 (1.7%)
Dual protection 6 (10.0%)
Time between deliveries in years (n ¼ 71)
Mean (SD) 3.7 (1.6)
Mode of delivery (n ¼ 78)
Normal vertex 75 (96.2%)
Birth weight in grams (n ¼ 74)
Mean (SD) 3094 (490)
Child sex (n ¼ 80)
Male 42 (52.5%)
Age of second children in months (n ¼ 81)
Mean (SD) 23 (17)
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1.22]). The mean duration of exclusive breastfeeding in the
older siblings was similar to those who were HIV-infected
and those who were uninfected (3.1 months [sd 2.8] and
3.0 months [sd 2.5], respectively). At the subsequent preg-
nancy, HIV-infected children had a similar duration of exclu-
sive breastfeeding periods (4.2 months [sd 2.6] versus 6.2
months [sd 3.3] for uninfected children, OR 0.76 [0.57–
1.02]).
Antiretroviral drugs
None of the mothers from the initial pregnancy were on
highly active antiretroviral drugs (HAART). At the sub-
sequent pregnancy, 8.7% of those on HAART transmitted
HIV compared to 9.3% who were not (OR 1.08 [0.14–
12.82]). At the initial pregnancy 37.5% did not receive
single dose nevirapine transmitted versus 36.8% of those
who did receive nevirapine (OR 1.12 [0.23–5.34]). For the
subsequent pregnancy, the percentages were 22.2 and 10.2,
respectively (OR 2.51 [0.43–13.37]; see Table 2).
Maternal disease
Viral loads and CD4 counts were not done for the women at
the initial pregnancy as it was not part of the standard of care
at the time. Among the subsequent births 10 mothers who
had CD4 counts of less than 200/mL, one (10%) had an
HIV-infected child and three (7.1%) of the mothers with
CD4 counts above or equal to 200/mL had a subsequent
HIV-infected child (OR 1.44 [0.02–20.43]).
Discussion
InthisstudypopulationtheHIVverticaltransmissionatalater
pregnancy was two-ﬁfths of the prior pregnancy in the same
women. This could be attributed to a higher proportion of
women on HAART (35%), compared to none on the initial
pregnancy, and a longer exclusive breastfeeding period. This
impliesthat they were given bettercounselling and early diag-
nosisandtreatment ofmastitiswhichare knownrisk factors of
HIV transmission.
10, 12 It is of note (although not statistically
signiﬁcant) that HIV-infected children at a subsequent preg-
nancy had shorter exclusive breastfeeding periods – four
months versus six months for the HIV-uninfected children –
while the mean duration of breastfeeding was similar (10
months).
Another explanation could be that, at the initial preg-
nancy, the women were seroconverting with high viral
loads and, as a result, were more likely to transmit. It is
unfortunate that viral loads were not done on these women
in this setting.
The women were counselled on dual contraception in order
to prevent re-infection with HIV but only a small proportion
reported using dual contraception (which included the
condom) as their method and the majority were using the
pill. It is important to note that the mean time between the
deliveries was 3.7 years which could suggest that the pregnan-
cies were planned. Thirty percent of the women in this study
had also changed their spouses which could explain their
desire to have children. In a study by Olufemi et al. which
determined the extent of fertility desires in HIV-infected
patients, 63.7% of the 147 participants expressed the desire
for children even though 50.4% already had two or more
children.
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This was a small cross sectional study after a ceased
cohort study and we were unable to explore other factors
associated with HIV transmission. We did not have complete
follow up of the ﬁrst pregnancies which might have inﬂu-
enced our transmission rates. Some of the children died
before receiving deﬁnitive HIV testing. However, our main
point is that the HIV transmission rates at subsequent preg-
nancies might be lower because of improved PMTCT in
our breastfeeding resource-limited setting. This is an impor-
tant factor when counselling HIV-infected women who want
to have more children and we recommend increasing access
to maternal HAART from 35% to 100% in our setting.
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Table 2 Factors associated with HIV transmission at subsequent pregnancy
Factor HIV-infected children HIV-uninfected children
Unadjusted odds ratio (95%
conﬁdence interval)
Maternal CD4 count n ¼ 4 n ¼ 48
. ¼200 3 (7.1%) 39 (92.9%) 1
,200 1 (10.0%) 9 (90.0%) 1.44 (0.02–20.43)
Maternal HAART n ¼ 6 n ¼ 60
On treatment 2 (8.7%) 21 (91.3%) 1
Not on treatment 4 (9.3%) 39 (90.7%) 1.08 (0.14–12.82)
Mother and child nevirapine n ¼ 9 n ¼ 58
Yes 5 (10.2%) 44 (89.2%) 1
No 4 (22.2%) 14 (77.8%) 2.51 (0.43–13.37)
Duration of exclusive breastfeeding in months n ¼ 9 n ¼ 55
Mean (SD) 4.1 (2.6) 6.2 (3.3) 0.76 (0.57–1.02)
Duration of breastfeeding in months n ¼ 9 n ¼ 55
Mean (SD) 10.0 (7.2) 10.1 (5.9) 1.0 (0.88–1.12)
HAART, highly active antiretroviral therapy
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